We show that adjuvant anti-PD1 is ineffective following surgery in mice that lack pre-existing anti-tumor immunity, but tumor antigen-specific T-cell transfer combines with anti-PD1 to prevent local recurrence and cure a subset of mice. Here, PDCD1 is linked to neoplasm.